Janet Kinney
Neonatal-Perinatal Medicine · Grapevine, TXNPI 1780650192
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $421 and has fallen 61.8% since, to $161 in 2025. Among neonatal-perinatal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$365
- Pfizer$254
- Kaleo, Inc.$132
- Takeda Pharmaceuticals U.S.A., Inc.$126
- Merck$120
- Ironshore Pharmaceuticals Inc.$110
- plus $642 from 18 others
What the payments were for
- Food & beverage$1,751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 16 | $365 |
| Pfizer | 14 | $254 |
| Kaleo, Inc. | 8 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $126 |
| Merck | 7 | $120 |
| Ironshore Pharmaceuticals Inc. | 6 | $110 |
| Cranial Technologies, Inc | 7 | $109 |
| Adlon Therapeutics L.p. | 5 | $93 |
| Tris Pharma Inc | 5 | $80 |
| Sanofi Pasteur Inc. | 4 | $65 |
| GSK | 2 | $40 |
| Phadia US Inc. | 2 | $32 |
| Genentech USA, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Medline Industries LP | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Neos Therapeutics, LP | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Seqirus USA Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Abbott | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Mission Pharmacal Company | 1 | $12 |
How this compares
$1,751 in reported general payments places this provider in the 95th percentile of 352 neonatal-perinatal medicine providers in Texas.
Other neonatal-perinatal medicine in Grapevine
- Gwieneverea BrandonFort Hood$141K
- Melissa TilleyCorpus Christi$91K
- Bheru GandhiHouston$33K
- Rashmin SavaniDallas$25K
- Zubin ShahDallas$24K
- Venkatakrishna KakkilayaDallas$22K
- Tiffany McKee GarrettHouston$12K
- Sunil JainGalveston$9K
- Jessica MorseDallas$6K
- Stephanie DealHouston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.